期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

血管活性肠肽调节淋巴细胞分化的研究进展 被引量：5

Advance on vasoactive intestinal peptide regulating lymphocyte differentiation
原文传递
导出
摘要 血管活性肠肽是免疫系统中具有重要免疫调节作用的神经肽。近年的研究表明,血管活性肠肽通过多条途径产生促进Th2细胞应答和抑制Thl细胞增殖,影响B细胞的分化,抑制NK细胞的活性为特点的免疫应答。本文就血管活性肠肽在调节淋巴细胞分化的研究进展作一综述。 Vasoactive intestinal peptide （VIP） is the most important neuropeptide in immune system. The recent researches indicated that VIP enhanced respondence of Th2 cell, inhibited proliferation of Thl cell, impacted differentiation of B cell, and inhibited activity of NK cell through several pathways. This article mainly reviewed the advance on VIP regulating lymphocyte differentiation in recent years.
作者 王翀 李国华
机构地区 南昌大学第一附属医院消化科
出处 《免疫学杂志》 CAS CSCD 北大核心 2010年第3期275-277,共3页 Immunological Journal
基金 国家自然基金资助项目(30760086)
关键词 VIP 淋巴细胞分化 NK细胞 Vasoaetive intestinal peptide Lymphocyte differentiation NK cell
分类号 R392 [医药卫生—免疫学]
  • 相关文献

参考文献20

  • 1Diebold SS. Activation of dendritic cells by toll-like receptors and C-type lectins [J]. Handb Exp Pharmacol, 2009, 188: 3-30.
  • 2Van Kooyk Y.C-type lectins on dendritic cells: key modulators for the induction of immune responses [J]. Biochem Soc Trans, 2008, 36(6): 1478-1481.
  • 3Lu J, Zheng MH, Yan J, et al. Effects of vasoactive intestinal peptide on phenotypic and functional maturation of dendritic cells[J]. Int Immunopharmacol, 2008, 8 (10): 1449-1454.
  • 4张松照,沈建根,潘建平.VIP选择性分化Th细胞的研究进展[J].国外医学（免疫学分册）,2005,28(2):65-68. 被引量：9
  • 5McClellan SA, Zhang Y, Barrett RP, et al. Substance P promotes susceptibility to Pseudomonas aeruginosa keratitis in resistant mice: anti-inflammatory mediators downregulated [J]. Invest Ophthalmol Vis Sci, 2008, 49 (4): 1502-1511.
  • 6王伟,席晔斌,王保国,陈广洁,沈天伟,包士三,李伟毅.血管活性肠肽对leydig细胞分泌的IL-1、IL-6和TGF-β的影响[J].免疫学杂志,2006,22(2):147-150. 被引量：6
  • 7Chorny A, Gonzalez Rey E, Delgado M. Regulation of dendritic cell differentiation by vasoactive intestinal peptide: therapeutic applications on autoimmunity and transplantation[J]. Ann N Y Acad Sci, 2006, 1088: 187-194.
  • 8Delgado M, Gonzalez Rey E, Ganea D. VIP/PACAP preferentially attract Th2 effectors through differential regulation of chemokine production by dendritic cells[J]. FASEB J, 2004, 18 (12): 1453-1455.
  • 9Chorny A, Gonzalez Rey E, Fernandez Martin A, et al.Vasoactive intestinal peptide induces regulatory dendritic cells with therapeutic effects on autoimmune disorders [J]. Proc Natl Acad Sci USA, 2005, 102 (38): 13562-13567.
  • 10翁跃颂,潘建平（审校者）.血管活性肠肽对树突状细胞免疫调节作用研究进展[J].国际免疫学杂志,2006,29(2):77-80. 被引量：8

二级参考文献56

  • 1Metwali A,Blum AM,Elliott DE,et al.IL-4 inhibits vasoactive intestinal peptide production by macrophages[J].Am J Physiol Gastrointest Liver Physiol,2002,283(1):G115-G121.
  • 2Delgado M,Gonzalez RE,Ganea D.VIP/PACAP preferentially attract Th2 effectors through differential regulation of chemokine production by dendritic cells[J].FASEB J,2004,18(1):1-22.
  • 3Jiang X,Jing H,Ganea D.VIP and PACAP down-regulate CXCL10 (IP-10) and up-regulate CCL22 (MDC) in spleen cells[J].J Neuroimmunol,2002,133(1-2):81-94.
  • 4Delgado M,Abad C,Martinez C,et al.Vasoactive intestinal peptide prevents experimental arthritis by downregulating both autoimmune and inflammatory components of the disease[J].Nat Med,2001,7(5):563-568.
  • 5Pozo D,Delgado M.The many faces of VIP in neuroimmunology:a cytokine rather a neuropeptide?[J].FASEB J,2004,18(12):1325-1334.
  • 6Delgado M.VIP:a very important peptide in T helper differentiation[J].Trends Immunol,2003,24(5):221-224.
  • 7Martinez C,Delgado M,Abad C,et al.Regulation of VIP production and secretion by murine lymphocytes[J].J Neuroimmunol,1999,93(1-2):126-138.
  • 8Vassiliou E,Jiang X,Delgado M.Th2 lymphocytes secrete functional VIP upon antigen stimulation[J].Arch Physiol Biochem,2001,109(4):365-368.
  • 9Lara-Marquez M,O'Dorisio M,O'Dorisio T,et al.Selective gene expression and activation-dependent regulation of vasoactive intestinal peptide receptor type 1 and type 2 in human T cells[J].J Immunol,2001,166(4):2522-2530.
  • 10Laburthe M,Couvineau A,Marie JC.VPAC receptors for VIP and PACAP[J].Receptors Channels,2002,8(3-4):137-153.

共引文献23

同被引文献43

  • 1贾彦敏,王树荣.β-内啡肽与中医“脾”的关系[J].浙江中医药大学学报,2010,34(5):795-796. 被引量：6
  • 2肖林,杨军,胡静,梁新华,李慧增,肖胤.水通道蛋白-1,5在干燥综合征小鼠下颌下腺中的表达[J].中国口腔颌面外科杂志,2005,3(4):325-329. 被引量：7
  • 3赵岩,张奉春.原发性干燥综合征的治疗[J].中华全科医师杂志,2006,5(4):203-205. 被引量：7
  • 4郝静,席晔斌,王伟,王保国,蒋黎华,陈广洁,李伟毅.血管活性肠肽抑制实验性类风湿性关节炎的研究[J].现代免疫学,2006,26(6):483-487. 被引量：6
  • 5Moody TW, ho T, Osefo N, etal. VIP and PACAP: recent insights into their functions/roles in physiology and disease from molecular and genetic studies[J]. Curr Opin Endocrinol Diabetes Obes, 2011, 18: 61-67.
  • 6Itoh A, Tsujikawa T, Fujiyama Y, et al. Enhancement of aquaporin-3 by vasoactive intestinal polypeptide in a human colonic epithelial cell line[J]. J Gastroenterol Hepatol, 2003, 18: 203-210.
  • 7Ma L, Huang YG, He H, et al. Postnatal expression and denervation induced up-regulation of aquaporin-5 protein in rat sweat gland[J]. Cell Tissue Res, 2007, 329: 25-33.
  • 8Delgado M, Abad C, Martinez C, etal. Vasoactive intestinal peptide prevents experimental arthritis by downregulating both autoimmune and inflammatory components of the disease [J]. Nat Med, 2001, 7: 563-568.
  • 9Lodde BM, Mineshiba F, Wang J, et al. Effect of human va- soactive intestinal peptide gene transfer in a murine model of Sjogren's syndrome[J]. Ann Rheum Dis, 2006, 65: 195- 200.
  • 10Katsifis GE, Rekka S, Moutsopoulos NM, et al. Systemic and local interleukin-17 and linked cytokines associated with Sjogren's syndrome immunopathogenesis[J]. Am J Pathol, 2009, 175: 1167-1177.

引证文献5

二级引证文献27

免疫学杂志
2010年 第3期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部